The FDA has approved alemtuzumab (Lemtrada) for the treatment of patients with relapsing forms of multiple sclerosis.
HCPLive Staff
Advertisement
Articles by HCPLive Staff
The FDA has approved a supplemental new drug application for avanafil (Stendra) to treat erectile dysfunction in men.
Advertisement
Latest Updated Articles
- FDA Approves sNDA for Oral Erectile Dysfunction Treatment
September 18th 2014
- FDA Approves Alemtuzumab for Relapsing Forms of Multiple Sclerosis
November 15th 2014
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Biosimilar Conversation Nobody Is Having at the Pharmacy Counter: Why Adoption Is Still Struggling and What We Can Do About It
2
Medicare Is Finally Covering GLP-1s for Weight Loss: What the Bridge Program Means for Your Practice
3
FDA Narrows Compounding Rules for GLP-1s: How Pharmacists Should Respond
4
Updated 2025-2026 COVID-19 Vaccine Nearly Halved ED Visits, Hospitalizations in CDC-Funded Study
5